Page last updated: 2024-08-18

pyrazolanthrone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

pyrazolanthrone has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, R; Han, Y; Huang, S; Li, M; Li, W; Ma, C; Mao, Z; Shi, L; Su, X; Wang, W; Xie, Y; Zhu, Z1
Tian, QY; Wang, YS; Wei, ZF; Zhang, YX; Zhou, HX; Zhou, JP1
Li, H; Wang, Y; Wei, Z; Zhang, Y; Zhang, Z; Zhou, H1

Other Studies

3 other study(ies) available for pyrazolanthrone and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease.
    Neuroscience research, 2004, Volume: 48, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anthracenes; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; MPTP Poisoning; Neurons

2004
[Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2007, Volume: 27, Issue:8

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anthracenes; Blotting, Western; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Dopamine; Gene Expression Regulation, Enzymologic; Humans; Immunohistochemistry; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Neurons; Parkinson Disease; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-jun; Substantia Nigra

2007
JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Journal of the neurological sciences, 2009, Oct-15, Volume: 285, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anthracenes; Cell Death; Cyclooxygenase 2; Disease Models, Animal; Dopamine; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Movement Disorders; Neurons; Parkinson Disease; Parkinsonian Disorders; Phosphorylation; Proto-Oncogene Proteins c-jun; Random Allocation; Substantia Nigra

2009